Where plans lose momentum
At Fierce Biotech Week, PMO Partners hosted a discussion on the practical obstacles between a signed agreement and a successful tech transfer. Harry Georgiades moderated the session with Amber Monaghan and Kindeva Drug Delivery’s John Wichelt.
A shared execution discipline
The panel highlighted the risk of bringing sponsors and CDMOs together before internal teams agree on scope, materials, quality expectations, and timing. Participants emphasized realistic commitments, early risk planning, and shared ownership across organizations. Their central message: protect front-end planning and work as an integrated team so speed does not come at the expense of quality. This is a historical event recap.
An edited item from the company’s news archive. Event dates, recognition and organizational details reflect the period described.